PDF下载 ( 959 KB)
Advances in genetic susceptibility to nonalcoholic fatty liver disease
-
-
[1]Fan JG, Farrell GC.Epidemiology of non-alcoholic fatty liver dis-ease in China[J].J Hepatol, 2009, 50 (1) ∶204-210. [2] Chen CH, Huang MH, Yang JC, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults[J]. J Clin Gastroenterol, 2006, 40 (8) ∶745-752. [3]Struben VM, Hespenheide EE, Caldwell SH.Nonalcoholic steato-hepatitis and cryptogenic cirrhosis within kindreds[J].Am J Med, 2000, 108 (1) ∶9-13. [4]Willner IR, Waters B, Patil SR, et al.Ninety patients with nonal-coholic steatohepatitis:insulin resistance, familial tendency, and severity of disease[J].Am J Gastroenterol, 2001, 96 (10) ∶2957-2961. [5]Abdelmalek MF, Liu C, Shuster J, et al.Familial aggregation of insulin resistance in first-degree relatives of patients with nonalco-holic fatty liver disease[J].Clin Gastroenterol Hepatol, 2006, 4 (9) ∶1162-1169. [6]Schwimmer JB, Celedon MA, Lavine JE, et al.Heritability of non-alcoholic fatty liver disease[J].Gastroenterology, 2009, 136 (5) ∶1585-1592. [7]Browning JD, Kumar KS, Saboorian MH, et al. Ethnic differences in the prevalence of cryptogenic cirrhosis[J]. Am J Gastroenterol, 2004, 99 (2) ∶292-298. [8]Browning JD, Szczepaniak LS, Dobbins R, et al.Prevalence of he-patic steatosis in an urban population in the United States:impact of ethnicity[J].Hepatology, 2004, 40 (6) ∶1387-1395. [9]Schwimmer JB, Mcgreal N, Deutsch R, et al. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents[J]. Pediatrics, 2005, 115 (5) ∶e561-e565. [10]Wagenknecht LE, Scherzinger AL, Stamm ER, et al.Correlates and heritability of nonalcoholic fatty liver disease in a minority co-hort[J].Obesity (Silver Spring) , 2009, 17 (6) ∶1240-1246. [11]Mohanty SR, Troy TN, Huo D, et al.Influence of ethnicity on his-tological differences in non-alcoholic fatty liver disease[J].J Hepatol, 2009, 50 (4) ∶797-804. [12]Weston SR, Leyden W, Murphy R, et al.Racial and ethnic distri-bution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease[J].Hepatology, 2005, 41 (2) ∶372-379. [13]Brouwers MC, Cantor RM, Kono N, et al. Heritability and genetic loci of fatty liver in familial combined hyperlipidemia[J]. J Lipid Res, 2006, 47 (12) ∶2799-2807. [14]Adeyemo A, Luke A, Cooper R, et al. A genome-wide scan for body mass index among Nigerian families[J]. Obes Res, 2003, 11 (2) ∶266-273. [15]Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease[J]. Nat Genet, 2008, 40 (12) ∶1461-1465. [16]Kotronen A, Johansson LE, Johansson LM, et al.A common vari-ant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans[J].Diabetologia, 2009, 52 (6) ∶1056-1060. [17]Sookoian S, Castano GO, Burgueno AL, et al. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity[J]. J Lipid Res, 2009, 50 (10) ∶2111-2116. [18]Kantartzis K, Peter A, Machicao F, et al.Dissociation between fat-ty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase3gene[J].Diabetes, 2009, 58 (11) ∶2616-2623. [19]Yuan X, Waterworth D, Perry JR, et al.Population-based ge-nome-wide association studies reveal six loci influencing plasma levels of liver enzymes[J].Am J Hum Genet, 2008, 83 (4) ∶520-528. [20]Baulande S, Lasnier F, Lucas M, et al.Adiponutrin, a transmem-brane protein corresponding to a novel dietary-and obesity-linked mRNA specifically expressed in the adipose lineage[J].J Biol Chem, 2001, 276 (36) ∶33336-33344. [21]Lake A C, Sun Y, Li JL, et al.Expression, regulation, and tri-glyceride hydrolase activity of Adiponutrin family members[J].JLipid Res, 2005, 46 (11) ∶2477-2487. [22]Jenkins C M, Mancuso D J, Yan W, et al.Identification, cloning, expression, and purification of three novel human calcium-inde-pendent phospholipase A2family members possessing triacylglycerol lipase and acylglycerol transacylase activities[J].J Biol Chem, 2004, 279 (47) ∶48968-48975. [23]Marra F, Bertolani C.Adipokines in liver diseases[J].Hepatolo-gy, 2009, 50 (3) :957-969. 期刊类型引用(14)
1. 许岩岩. 凝血酶原时间与血小板参数检验对肝硬化患者肝损伤情况的评估作用. 临床医学研究与实践. 2024(08): 93-96 . 
百度学术2. 陈大同，孙跃，梁明辉，金成，李公启，许东滨，张立平. 基于深度学习的淋巴细胞热图分析及红细胞计数预测老年原发性肝癌患者术后生存期的临床价值. 中国老年学杂志. 2024(08): 1813-1816 . 百度学术3. 张月华，马玉琳，任爱莉，张月靖. 网织红细胞血红蛋白含量在诊断单采血小板铁缺乏中的应用. 系统医学. 2024(09): 33-37 . 百度学术4. 王燚鑫，胡梦茹，赵永红，衣桂荣，陈爱荣. TyG、PLR与代谢相关脂肪性肝病合并慢性乙型肝炎患者肝纤维化的关系研究. 现代生物医学进展. 2024(14): 2694-2698+2693 . 百度学术5. 刘华柱，张欢，张献文. 失代偿期肝硬化患者门静脉血栓形成的相关因素分析及D-二聚体/血小板比值的预测价值. 临床消化病杂志. 2024(04): 270-274 . 百度学术6. 王凯，郭爱荣，王艳. PLT、IGFBP-3、ALB联合诊断对肝硬化上消化道出血的预测价值. 华夏医学. 2024(04): 145-150 . 百度学术7. 张嘉欣，韩文，葛彪，白莆菥. 肝硬化食管胃底静脉曲张无创预测的研究进展. 肝脏. 2024(08): 1005-1009 . 百度学术8. 孔钦香，盛吉芳. 慢性乙肝肝硬化患者肝性脑病不同分级与肝脏储备功能的相关性. 中国微生态学杂志. 2023(02): 190-196 . 百度学术9. 田丽，许勤华，郭旭. RPR预测感染性休克患者发生急性呼吸窘迫综合征的价值. 河南医学高等专科学校学报. 2023(01): 13-17 . 百度学术10. 于巧丽，张丽利. 非酒精性脂肪性肝炎外周血NLR、RDW、MPV变化及其意义探讨. 罕少疾病杂志. 2023(04): 65-66+81 . 百度学术11. 何宏材，苏鹏宇，侯立朝，樊海宁. 红细胞分布宽度与血小板计数比值和血小板-白蛋白-胆红素评分预测肝脏多房棘球蚴病术后并发症的列线图构建. 中国普外基础与临床杂志. 2023(07): 795-801 . 百度学术12. 张小娟，马昕. 红细胞分布宽度与血小板计数比值与慢性阻塞性肺疾病急性发作风险的相关性分析. 检验医学与临床. 2023(19): 2885-2888 . 百度学术13. 梁忆佳，李金洋，赵氲. 肝硬化患者凝血酶原时间及血小板指标检验的临床价值. 中国老年学杂志. 2023(22): 5458-5460 . 百度学术14. 王广春，曹洋. 红细胞分布宽度及其衍生物作为消化系统炎症和肿瘤疾病标志物的研究进展. 南京医科大学学报(自然科学版). 2023(12): 1764-1770 . 百度学术其他类型引用(4)
-
百度学术
下载:
